Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT06658886
Recruiting Observational

Comparison of the Efficacy of Ultrasound-Guided Corticosteroid Injection and Paraffin Therapy in Carpal Tunnel Syndrome

NCT06658886 · tracked via the Priya Life Science Turkey tracker
Sponsor
Beylikduzu State Hospital
Phase
Observational
Started
2024-11-10
Last updated
2024-12-12

Condition(s) studied

Carpal Tunnel Syndrome

Investigational drug(s) / intervention(s)

No intervention

No intervention: No intervention

Study summary

The aim of this study is to compare the efficacy of paraffin therapy, a physical therapy modality, and ultrasound-guided corticosteroid injection in the treatment of carpal tunnel syndrome, the most common entrapment neuropathy. By doing so, the study will evaluate the effectiveness and feasibility of these two alternative, low-side-effect treatments for managing this frequently encountered condition.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Patients aged 18-65. * Diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies. * Received either ultrasound-guided corticosteroid injection or paraffin therapy. * Symptoms persisting for at least 3 months. Exclusion Criteria: * Diagnosis of other conditions causing neuropathic symptoms (e.g., polyneuropathy, brachial plexopathy, thoracic outlet syndrome). * History of previous injection or surgery for carpal tunnel syndrome.

Primary outcome measure(s)

  • Visual Analog Scale (VAS): — 0 day, 4th week and 12th week
    The VAS will be used to measure pain intensity. Patients will mark their pain level on a 10 cm scale, where 0 represents "no pain" and 10 represents the "worst imaginable pain." This will be evaluated at baseline, and at the 4th and 12th weeks post-treatment.
  • Boston Carpal Tunnel Syndrome Questionnaire Symptom Severity Scale (BCTQ-SSS) — 0 day, 4th week and 12th week
    The SSS assesses the severity of carpal tunnel symptoms such as pain, tingling, and numbness. The total score for this scale ranges from a minimum of 11 to a maximum of 55. A lower score indicates mild or no symptoms, while a higher score suggests more severe symptoms. As the score increases, the severity of symptoms worsens, with a score closer to 55 reflecting a significantly greater impact on daily life.
  • Boston Carpal Tunnel Syndrome Questionnaire Functional Status Scale (BCTQ-FSS) — 0 day, 4th week and 12th week
    The SSS assesses the severity of carpal tunnel symptoms such as pain, tingling, and numbness. The total score for this scale ranges from a minimum of 11 to a maximum of 55. A lower score indicates mild or no symptoms, while a higher score suggests more severe symptoms. As the score increases, the severity of symptoms worsens, with a score closer to 55 reflecting a significantly greater impact on daily life.

Trial sites (1)

FacilityCityRegionStatus
Beylikdüzü State Hospital Istanbul Beylikdüzü Recruiting

More Beylikduzu State Hospital trials in Turkey

Caregiver Burden in Parkinson's Disease Recruiting
Orthorexia Nervosa in Postmenopausal Osteoporosis Recruiting
Masseter Thickness, Bruxism, and Oral Behaviors in Chronic Neck Pain Recruiting
Ultrasonographic Evaluation of the Ulnar Nerve in Individuals With and Without Generalized Joint Hypermobility Starting soon
Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis Recruiting

Other trials for the same condition

Effects of Neurodynamic and Carpal Bone Mobilization in Mild-to-Moderate Carpal Tunnel Syndrome Starting soon
Comparison of the Efficacy of Different Treatment Methods in Patients With Carpal Tunnel Syndrome Active, not recruiting
Effectiveness of Matrix Rhythm Therapy on Carpal Tunnel Syndrome Recruiting
Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome Recruiting
Hand10 Questionnaire in Individuals With Carpal Tunnel Syndrome Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06658886 on ClinicalTrials.gov ↗ ← All trials in Turkey